EDIT Gamma Exposure (GEX)

Net gamma exposure for Editas Medicine Inc (EDIT) options was positive at the Nov 4, 2026 close, about $40.54K per 1% move in the stock. It has been positive on 19 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.

Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Gamma Exposure by Strike

Showing results for EDIT, 2026-11-20(m), calls & puts

       

Gamma Exposure Stats

Showing results for EDIT, 2026-11-20(m), calls & puts



Net Gamma Exposure by Expiration

Showing results for EDIT, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net GEX Call GEX Put GEX Call Wall Put Wall Gamma Flip

EDIT Gamma Exposure FAQ

What is gamma exposure (GEX)?

Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.

Is EDIT gamma exposure positive or negative?

Editas Medicine net gamma exposure was positive on Nov 4, 2026, at $40.54K. It has been positive on 19 of the last 20 trading days.

How has EDIT gamma exposure changed recently?

Editas Medicine net gamma exposure went from $16.12K on Oct 7, 2026 to $40.54K on Nov 4, 2026. See the EDIT gamma exposure history for a longer view.

What is Editas Medicine Inc?

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases.

Give feedback on this chart